查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1493296

胰蛋白酶市场规模、份额、趋势分析报告：按原料、按应用、按最终用途、按地区、细分市场预测，2024-2030

Trypsin Market Size, Share & Trends Analysis Report By Source (Porcine, Bovine), By Application (Biotechnology & Pharmaceutical Industry, Food Industry), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10个工作天内

价格

胰蛋白酶市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球胰蛋白酶市场规模预计将达到1.315亿美元，预计2024年至2030年复合年增长率为5.3%。

胰蛋白酶在製药、食品科学研究、清洁剂和皮革加工等各个行业中的日益采用可能会推动市场成长。此外，正在进行各种研究来评估胰蛋白酶在诊断癌症、急性胰臟炎、吸收不良和囊肿纤维化等多种疾病方面的潜力，并且预计将越来越关注药物发现研究和开发。增长。

胰蛋白酶因其水解蛋白质的特殊消化功能而被广泛应用于医药、食品、环保等产业的研发。胰蛋白酶作为内分泌疾病和临床外科内服药物的原料。酵素催化剂的使用正在扩大在製药、食品和饮料以及食品工业的商业过程。这些酵素在食品、製药和饲料行业中的使用非常高效，因为它们有助于减少废弃物。此外，胰蛋白酶 VI 是胰蛋白酶的最佳来源，可用于营养食品，作为动物和人类的发炎治疗和消化食品。

已经进行了各种研究来评估其诊断多种疾病的潜力，包括癌症、急性胰臟炎、吸收不良和囊肿纤维化。研发支出增加，新药上市增加，FDA核准。

胰蛋白酶市场报告亮点

  • 从来源来看，由于其在临床诊断、研究、食品和饮料行业以及肉类嫩化领域的突出应用，牛细分市场在 2023 年以 60.07% 的最高收益占有率引领市场。
  • 根据供应来源，生猪细分市场预计在预测期内将以最快的复合年增长率成长。
  • 从应用来看，生物技术和製药行业预计将在 2023 年以 56.19% 的最高收益占有率占据市场，并预计在预测期内呈现最快的复合年增长率。
  • 对药物发现和药物开发的日益关注正在进一步推动成长。
  • 由于各种癌症的盛行率不断上升、购买力平价较高、政府对优质医疗保健的支持以及报销的可及性等因素，北美地区在 2023 年以最高的收益占有率占据市场主导地位。
  • 2023年12月，商务用酵素相关产品和服务的全球先驱创新 Enzymes推出了蛋白水解酶组合产品，包括胰蛋白酶-胰凝乳蛋白酶。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章胰蛋白酶市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/补充市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 胰蛋白酶市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章胰蛋白酶市场：原料预估及趋势分析

  • 世界各地的胰蛋白酶：原料仪表板
  • 世界各地的胰蛋白酶：原料差异分析
  • 世界胰蛋白酶：依原料、收益2018-2030
  • 2018-2030年市场规模、预测及趋势分析
  • 猪
  • 牛
  • 其他的

第五章胰蛋白酶市场：应用估算与趋势分析

  • 世界各地的胰蛋白酶：应用型仪表板
  • 全球胰蛋白酶：应用类型差异分析
  • 世界胰蛋白酶：依应用分类，收益2018-2030
  • 2018-2030年市场规模、预测及趋势分析
  • 生物技术和製药业
  • 食品工业
  • 化妆品/个人护理
  • 废弃物处理
  • 其他的

第六章胰蛋白酶市场：最终用途估计与趋势分析

  • 世界各地的胰蛋白酶：最终用途类型仪表板
  • 世界各地的胰蛋白酶：最终用途类型的变化分析
  • 全球胰蛋白酶：2018-2030 年按最终用途类型分類的收益
  • 2018-2030年市场规模、预测及趋势分析
  • 研究
  • 诊断
  • 工业用途

第七章胰蛋白酶市场：区域估计与趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
    • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2023年主要企业市场占有率分析
    • Thermo Fisher Scientific, Inc
    • Promega Corporation
    • Agilent Technologies, Inc.
    • Merck Millipore
    • Novozymes
    • Sartorius AG
    • BIOZYM
    • Bovogen Biologicals
    • Zymetech
    • BBI Solutions
    • Linzyme Biosciences
    • PromoCell GmbH.
Product Code: GVR-4-68040-273-6

Trypsin Market Growth & Trends:

The global trypsin market size is anticipated to reach USD 131.5 million by 2030 and is projected to grow at a CAGR of 5.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing adoption of trypsin across various industries, such as pharmaceuticals, food science research, detergents, and leather-bating, is likely to drive the market growth. Where as various research studies are being conducted to evaluate its potential in diagnosing a wide range of disorders, such as cancer, acute pancreatitis, malabsorption, and cystic fibrosis, along with increasing focus on drug discovery and development is expected to further propel the market growth.

Trypsin is widely being used in R&D in pharmaceutical, food, and environmental industries, owing to its special digestive functions of hydrolyzing proteins. It acts as a raw material for internal medicine in endocrine diseases and clinical surgery. The use of enzyme catalysts has been scaled up for commercial processes in the pharmaceutical, beverages, and food industries. These enzymes help in waste reduction, which makes them highly efficient to be used in food, pharmaceuticals, and feed industries. Moreover, the best source of trypsin, TRYPSIN VI, has found nutraceutical use as an anti-inflammatory treatment and a digestive supplement for veterinary & human applications.

Various research studies are being conducted to evaluate its potential in diagnosing a wide range of disorders, such as cancer, acute pancreatitis, malabsorption, and cystic fibrosis. Increase in R&D expenditure, the rising drug launches, and FDA approvals.

Trypsin Market Report Highlights:

  • Based on source, the bovine segment led the market with the largest revenue share of 60.07% in 2023, owing to prominent application in field of clinical diagnostics, research, food and beverage industry and meat tenderization
  • Based on source, the porcine segment is expected to grow at the fastest CAGR over the forecast period
  • Based on application, the biotechnology and pharmaceutical industry segment held the market with the largest revenue share of 56.19% in 2023. and is further anticipated to witness the fastest CAGR over the forecast period
  • The increasing focus on drug discovery and development is further propelling growth
  • North America dominated the market with the largest revenue share of 40.71% in 2023, owing to factors such as increasing the prevalence of various cancer, high purchasing power parity, government support for quality healthcare, and availability of reimbursement
  • In Dec 2023, Creative Enzymes, a global pioneer in professional enzyme related products and services unveiled its combination product offerings for proteolytic enzymes such as Trypsin-Chymotrypsin, with this company aims at optimizing the speed and efficiency of the digestive process opening new possibilities for medical and pharmaceutical enhancements

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Source
    • 1.2.2. Application
    • 1.2.3. End-use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline.
  • 1.3. Research methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Source outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Trypsin Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of gastrointestinal disorders
      • 3.2.1.2. Increasing trypsin related studies and therapeutics
      • 3.2.1.3. Technological advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulations
      • 3.2.2.2. High cost of sourcing
  • 3.3. Trypsin Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Trypsin Market: Source Estimates & Trend Analysis

  • 4.1. Global Trypsin: Source Dashboard
  • 4.2. Global Trypsin: Source Movement Analysis
  • 4.3. Global Trypsin by Source, Revenue 2018 - 2030 (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Porcine
    • 4.5.1. Porcine Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Bovine
    • 4.6.1. Bovine Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Trypsin Market: Application Estimates & Trend Analysis

  • 5.1. Global Trypsin: Application Type Dashboard
  • 5.2. Global Trypsin: Application Type Movement Analysis
  • 5.3. Global Trypsin by Application Type, Revenue 2018 - 2030 (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Biotechnology and Pharmaceutical Industry
    • 5.5.1. Biotechnology and Pharmaceutical Industry Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Food Industry
    • 5.6.1. Food Industry Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Cosmetics and Personal Care
    • 5.7.1. Cosmetics and Personal Care Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Waste Treatment
    • 5.8.1. Waste Treatment Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Trypsin Market: End-use Estimates & Trend Analysis

  • 6.1. Global Trypsin: End Use Type Dashboard
  • 6.2. Global Trypsin: End-Use Type Movement Analysis
  • 6.3. Global Trypsin by End Use Type, Revenue 2018 - 2030 (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Research
    • 6.5.1. Research Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Diagnostics
    • 6.6.1. Diagnostics Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Industrial use
    • 6.7.1. Industrial use Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Trypsin Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. North America
    • 7.5.2. U.S.
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. Europe
    • 7.6.2. UK
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. France
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Spain
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Norway
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Sweden
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.9. Denmark
      • 7.6.9.1. Key country dynamics
      • 7.6.9.2. Regulatory framework
      • 7.6.9.3. Competitive scenario
      • 7.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Asia Pacific
    • 7.7.2. Japan
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. China
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. India
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. Australia
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. South Korea
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.7. Thailand
      • 7.7.7.1. Key country dynamics
      • 7.7.7.2. Regulatory framework
      • 7.7.7.3. Competitive scenario
      • 7.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Latin America
    • 7.8.2. Brazil
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Mexico
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.4. Argentina
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. MEA
    • 7.9.2. South Africa
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. Saudi Arabia
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. UAE
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.5. Kuwait
      • 7.9.5.1. Key country dynamics
      • 7.9.5.2. Regulatory framework
      • 7.9.5.3. Competitive scenario
      • 7.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Thermo Fisher Scientific, Inc
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Source benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Promega Corporation
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Source benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Agilent Technologies, Inc.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Source benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Merck Millipore
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Source benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Novozymes
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Source benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Sartorius AG
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Source benchmarking
      • 8.3.9.4. Strategic initiatives
      • 8.3.10.5. Neova Technologies
      • 8.3.10.6. Company overview
      • 8.3.10.7. Financial performance
      • 8.3.10.8. Source benchmarking
      • 8.3.10.9. Strategic initiatives
    • 8.3.11. BIOZYM
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Source benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Bovogen Biologicals
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Source benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Zymetech
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Source benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. BBI Solutions
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Source benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. Linzyme Biosciences
      • 8.3.15.1. Company Overview
      • 8.3.15.2. Financial Performance
      • 8.3.15.3. Source Benchmarking
      • 8.3.15.4. Strategic Initiatives
    • 8.3.16. PromoCell GmbH.
      • 8.3.16.1. Company overview
      • 8.3.16.2. Financial Performance
      • 8.3.16.3. Source Benchmarking
      • 8.3.16.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Trypsin market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 4 North America Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S. Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 7 U.S. Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 10 Canada Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe Trypsin market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 14 Europe Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 15 Europe Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Germany Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 17 Germany Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 18 Germany Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 20 UK Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 23 France Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 24 France Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Italy Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 26 Italy Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Spain Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 29 Spain Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Denmark Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 32 Denmark Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 33 Denmark Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Sweden Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 35 Sweden Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 36 Sweden Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Norway Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 38 Norway Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 39 Norway Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific Trypsin market, by region, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 China Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 45 China Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 46 China Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Japan Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 48 Japan Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 49 Japan Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 India Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 51 India Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 52 India Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 South Korea Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 54 South Korea Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 55 South Korea Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 Australia Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 57 Australia Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 58 Australia Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Thailand Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 60 Thailand Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 61 Thailand Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Latin America Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 63 Latin America Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 64 Latin America Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Brazil Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 66 Brazil Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 67 Brazil Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 68 Mexico Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 69 Mexico Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 70 Mexico Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 71 Argentina Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 72 Argentina Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 73 Argentina Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 MEA Trypsin market, by region, 2018 - 2030 (USD Million)
  • Table 75 MEA Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 76 MEA Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 77 MEA Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 South Africa Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 79 South Africa Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 80 South Africa Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 84 UAE Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 85 UAE Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 86 UAE Trypsin market, by end-use, 2018 - 2030 (USD Million)
  • Table 87 Kuwait Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Trypsin market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Trypsin market: market outlook
  • Fig. 14 Trypsin competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook.
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Trypsin market driver impact
  • Fig. 20 Trypsin market restraint impact
  • Fig. 21 Trypsin market strategic initiatives analysis
  • Fig. 22 Trypsin market: Source movement analysis
  • Fig. 23 Trypsin market: Source outlook and key takeaways
  • Fig. 24 Bovine market estimates and forecasts, 2018 - 2030
  • Fig. 25 Porcine market estimates and forecasts, 2018 - 2030
  • Fig. 26 Others market estimates and forecasts, 2018 - 2030
  • Fig. 27 Trypsin market: Application movement analysis
  • Fig. 28 Trypsin market: Application outlook and key takeaways
  • Fig. 29 Biotechnology and Pharmaceutical Industry market estimates and forecast, 2018 - 2030
  • Fig. 30 Food Industry market estimates and forecast, 2018 - 2030
  • Fig. 31 Cosmetics and Personal Care market estimates and forecast, 2018 - 2030
  • Fig. 32 Waste Treatment market estimates and forecast, 2018 - 2030
  • Fig. 33 Others market estimates and forecast, 2018 - 2030
  • Fig. 34 Trypsin market: End Use movement analysis
  • Fig. 35 Trypsin market: End Use outlook and key takeaways
  • Fig. 36 Research Studies market estimates and forecasts, 2018 - 2030
  • Fig. 37 Diagnostics market estimates and forecasts, 2018 - 2030
  • Fig. 38 Industrial use market estimates and forecasts, 2018 - 2030
  • Fig. 39 Global Trypsin market: Regional movement analysis
  • Fig. 40 North America market estimates and forecasts, 2018 - 2030
  • Fig. 41 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 42 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 43 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 44 UK market estimates and forecasts, 2018 - 2030
  • Fig. 45 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 46 France market estimates and forecasts, 2018 - 2030
  • Fig. 47 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 48 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 49 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 50 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 51 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 52 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 53 China market estimates and forecasts, 2018 - 2030
  • Fig. 54 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 55 India market estimates and forecasts, 2018 - 2030
  • Fig. 56 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 57 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 58 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 59 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 60 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 61 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 62 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 63 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 64 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 65 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 66 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 67 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 68 Market share of key market players- Trypsin market